Pediatric functional seizures: Demographics, clinical and psychological characteristics and risk factors

Sherifa Ahmed Hamed1, Ali Farrag ElHadad2, Mohamed Fawzy1

  • 1Department of Neurology and Psychiatry, Assiut University Hospital, Assiut, Egypt.

Epilepsy & Behavior : E&B
|February 17, 2026
PubMed

Insights

Pediatric functional seizures (FS), also known as psychogenic non-epileptic seizures (PNES), are common in epilepsy clinics, affecting approximately 15% of patients. Early diagnosis and management of FS are crucial to prevent long-term developmental issues.

Area of Science:

  • Neurology
  • Pediatrics
  • Psychiatry

Background:

  • Pediatric functional seizures (FS), or psychogenic non-epileptic seizures (PNES), are understudied compared to adult populations.
  • Understanding the prevalence, clinical characteristics, and predictors of pediatric FS is essential for improving patient outcomes.

Purpose of the Study:

  • To determine the prevalence of FS in pediatric epilepsy clinics.
  • To investigate the clinical patterns, behavioral characteristics, and risk predictors associated with pediatric FS.

Main Methods:

  • Patients were recruited from outpatient pediatric epilepsy clinics.
  • Data included demographics, clinical features, video-electroencephalography, psychiatric interviews, and psychometric questionnaires (Child Behavior Check List).

Main Results:

  • FS prevalence was 15.42% in pediatric epilepsy clinics; 5.14% had mixed epilepsy and FS.
  • FS predominantly affected adolescents (66.7%) with a mean age of 14 years, and diagnosis delay ranged from 4-14 months.
  • Patients with FS exhibited higher scores on the Child Behavior Check List (anxiety, somatization, inattention) and internalizing/externalizing behavior problems compared to controls and epilepsy patients.

Conclusions:

  • Functional seizures are a frequent diagnosis in pediatric epilepsy clinics, often misdiagnosed as epilepsy.
  • Psychosocial factors such as self-efficacy conflicts and school/family problems are significant predictors of FS.
  • Timely diagnosis and management of pediatric FS are critical to mitigate negative impacts on personality, social interactions, and academic performance.

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.7K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.4K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
258
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
334
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.1K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
338